This two-day masterclass, based on RQAs well established three-day Practical Pharmacovigilance Auditing course, will explore key phases of pharmacovigilance auditing. It will address the impact of the EU pharmacovigilance legislation on auditing and provide guidance on auditing pharmacovigilance systems at both the global and local organisational level. This course is designed for pharmacovigilance auditors, auditors new to pharmacovigilance and pharmacovigilance professionals to provide them with insight into developing and/or optimising a pharmacovigilance audit programme. In order to gain maximum benefit from the course, an understanding of pharmacovigilance is advantageous.
This course provides a wealth of information which will provide delegates with
Tutors will be comprised from the list below:
Consultant, Rigg UK Consulting Ltd (Course Principal)
Please note timings may be subject to alteration
|9.30||Welcome and Introductions and Introduction to the Workshops
The objectives of the workshops are defined and process and outputs described.
|10.00||Introduction to the EU PV Legislation Relating to PV Auditing and GVP Modules that Impact PV Auditing
EU PV legislation (relevant Regulations and Directives) and key highlights from Module I, II, IV relating to PV auditing.
||Audit Planning and Scheduling
Understanding and defining the PV Audit universe, applying risk-based audit strategy, using risk assessment and risk criteria, identifying an audit schedule and resourcing audits.
|11.45|| Audit Types, Processes and Preparation
Types of PV audits, QA audit process requirements and tools necessary to execute audit programmes.
Detailed information on how to prepare for audits (by audit type), common features in audit preparation and perhaps a table to show differences on preparation by audit types and planning individual audits (eg preparation, audit planning, audit conduct, audit reporting, CAPA management).
|13.30||Auditing Affiliates/Local Operating Companies
Auditing the processes and systems in place at local affiliate offices including post-marketing surveillance, clinical trials, medical information, regulatory, sales/marketing etc.
|14.30||Workshop 1 - Audit Schedule|
|15.00||Workshop 1 - Feedback|
|16.00||Case Processing (from all sources)
Auditing the processes and systems designed for processing clinical trial and post-marketing cases.
|9.00||Auditing the Roles and Responsibilities of the QPPV
Auditing the roles and responsibilities of the Qualified Person responsible for Pharmacovigilance.
|9.45||Elements of Risk Management System (Part 1).|
|11.00||Elements of Risk Management System (Part 2).|
|13.00|| Auditing Licensing/Marketing Partners
Contracts, safety data exchange agreements and oversight by the Marketing Authorisation Holder.
|13.45||Workshop 3 - Speed Auditing|
|14.15||Workshop 3 - Feedback|
|15.45||Regulatory Inspection and Audit of Quality Assurance
Are your audit programme and quality assurance function inspection ready?
Hints and tips on being the interviewee.
|16.30||Close of day|
Following requests from attendees of previous RQA events we are pleased to offer course material in PDF format for delegates attending this course.
The material will be emailed in advance of the course and RQA will not be providing any printed copies of the course notes during the training itself. Delegates wishing to have a hard copy of the notes should print these in advance to bring with them. Alternatively delegates are welcome to bring along their own portable devices to view the material during the training sessions.
You will also receive a copy of our booklet - "Pharmacovigilance Auditing"
Please see here for accommodation link - for course date 4th-5th November 2019.